In our ovarian carcinomas, platinum resistance was seen in 70% (14 of 20) of Nu-SIRT6-positive patients, but platinum resistance was only 30% (6 of 20) in Nu-SIRT6-negative patients. The gene discussed is SIRT6; the disease is ovarian carcinoma.